Investors Are Craving More from Curis Inc. [CRIS] Stocks: Here is Why

Over the past three months, Curis Inc. [CRIS] ended the trading day at $2.00 and exhibited a change of 6.38% with a 24 hour trading and reached upto the volume of 781.90K compared to its recorded trading volume of 3.29 million. CRIS generated a 1 year amount change with 11.73%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by 45.99% with an amount shift of 81.82% over the last month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


On 2, December 2020, Curis to Host Virtual Event to Discuss CA-4948 Clinical Data. According to news published on Yahoo Finance, – KOL Event featuring Dr. Amit Verma scheduled for Tuesday, December 8 at 8:00 a.m. ET -.

Analyst Birdseye View:

The most recent analyst activity for Curis Inc. [NASDAQ:CRIS] stock was on July 17, 2020, when it was Initiated with an Overweight rating from Cantor Fitzgerald, which also raised its 12-month price target on the stock to $4. Before that, on July 29, 2020, Laidlaw Recapitulated a Buy rating and elevated its amount target to $5. On October 24, 2017, Guggenheim Initiated a Buy rating and boosted its price target on this stock to $7. On March 02, 2016, Sun Trust Rbsn Humphrey Initiated a Buy rating and increased its price target to $3. On November 09, 2015, ROTH Capital Reiterated a Buy rating and decreased its price target to $5. On August 11, 2015, FBR Capital Initiated an Outperform rating and boosted its amount on this stock to $6. On January 22, 2015, Oppenheimer Reiterated an Outperform rating and boosted its target amount on this stock from $3 to $5. On January 21, 2015, ROTH Capital Reiterated a Buy rating and amplified its amount target to $6.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.62 and a peak of $3.59. Right now, according to Wall Street analyst the average 12-month amount target is $4.75. At the most recent market close, shares of Curis Inc. [NASDAQ:CRIS] were valued at $2.00.


Curis Inc. [NASDAQ:CRIS] most recently reported quarterly sales of 2.74 billion, which represented growth of -6.90%. This publicly-traded organization’s revenue is $357,286 per employee, while its income is -$1,147,893 per employee. This company’s Gross Margin is currently 95.10%, its Pretax Margin is -321.28, and its Net Margin is -321.28.

The Principal structure of this organization shows its whole liability to whole principal at 218.03 and the whole liability to whole assets at 178.23. It shows enduring liability to the whole principal at 217.45 and enduring liability to assets at 1.78 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 1.78 points at 1st support level, the second support level is making up to 1.57. But as of 1st resistance point, this stock is sitting at 2.14 and at 2.29 for 2nd resistance point.

Curis Inc. [CRIS] reported its earnings at -$0.11 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.13/share signifying the difference of 0.02 and 15.40% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.17 calling estimates for -$0.19/share with the difference of 0.02 depicting the surprise of 10.50%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Curis Inc. [NASDAQ:CRIS] is 3.10. Likewise, the Quick ratio is also the same, showing Cash ratio at 3.16. Now if looking for a valuation of this stock’s amount to sales ratio it’s 5.64.

Insider Stories

The most recent insider trade was by Dentzer James E, President & CEO, and it was the sale of 3094.0 shares on Jan 24. Dentzer James E, the President & CEO, completed a sale of 3658.0 shares on Jan 23.